Expert Interviews

Vaccine Hesitancy Often is Synonymous with Vaccine Confusion: Perspectives from Primary Care
August 11, 2021

The COVID-19 vaccine hesitancy echoed to this PCP from his multiethnic community is rooted in confusion. He talks about creating clarity, here.

Interview: The Vaccine-hesitant Patient Needs to Hear "Yes" from Primary Care
August 10, 2021

COVID-19 vaccine information that is culturally sensitive, clear, and concise may help reduce patient hesitation, but the PCP can shift a “maybe” to “yes.”

COVID-19 Vaccine Blame Game is a Poor Strategy, Yale PCP Advises
August 09, 2021

Patients unvaccinated against COVID-19 don't need blame; they may need more of your time, though, says this primary care physician.

Role of Bempedoic Acid in Clinical Practice
August 04, 2021

Experts discuss key takeaways from the review article “Role of Bempedoic Acid in Clinical Practice”, clinical implications, and the greatly anticipated CLEAR Outcomes trial.

Efficacy and Safety Data for Bempedoic Acid
August 04, 2021

Experts examine the safety and efficacy data presented within the review article, “Role of Bempedoic Acid in Clinical Practice.”

Preventive Cardiology after Framingham: Nathan D. Wong, PhD, MPH, Details the Evolution
July 28, 2021

Nathan D Wong, PhD, MPH, renowned in the field of preventive cardiology, reviewed for Patient Care the history of the field and his own pivotal contributions and also paid tribute to his lifetime mentors.

How to Help Patients Refine a Concept of Gut Health: Two Perspectives, One View
July 16, 2021

Patients interested in optimizing their own gut health have typically tried several approaches before they ask a clinician for help. Two specialists offer seasoned guidance on what helps most.

Neurology, Rheumatology, and the Gut Microbiome: Two Specialists Discuss
July 16, 2021

A neurologist and a rheumatologist sat down with Patient Care editors to talk about their focus on balance in the gut microbiome as an essential element of clinical care.

At ADA 2021, John Buse, MD, PhD, says US Must Focus on Control of Obesity, Other T2D Risk Factors
June 30, 2021

Diabetes investigator John Buse, MD, PhD, says laser focus on reducing T2D risk factors is equally as important as using the next right drug against the disease.

Inside GRADE: Exec Committee Member John Buse, MD, PhD, Toplines Study Results, Calls for More Head-to-Head Research
June 30, 2021

Dr Buse’s in-depth review of the GRADE study is followed by a discussion of the keen need for more comparative research and the many new questions the results have raised about optimal T2D therapy.